Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice
The innate immune system responds not only to bacterial signals, but also to non-infectious danger-associated molecular patterns that activate the NLRP3 inflammasome complex after tissue injury. Immune functions vary over the course of the day, but it is not clear whether these changes affect the ac...
Gespeichert in:
Veröffentlicht in: | Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2018-04, Vol.154 (5), p.1449-1464.e20 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1464.e20 |
---|---|
container_issue | 5 |
container_start_page | 1449 |
container_title | Gastroenterology (New York, N.Y. 1943) |
container_volume | 154 |
creator | Pourcet, Benoit Zecchin, Mathilde Ferri, Lise Beauchamp, Justine Sitaula, Sadicha Billon, Cyrielle Delhaye, Stéphane Vanhoutte, Jonathan Mayeuf-Louchart, Alicia Thorel, Quentin Haas, Joel T. Eeckhoute, Jérome Dombrowicz, David Duhem, Christian Boulinguiez, Alexis Lancel, Steve Sebti, Yasmine Burris, Thomas P. Staels, Bart Duez, Hélène M. |
description | The innate immune system responds not only to bacterial signals, but also to non-infectious danger-associated molecular patterns that activate the NLRP3 inflammasome complex after tissue injury. Immune functions vary over the course of the day, but it is not clear whether these changes affect the activity of the NLRP3 inflammasome. We investigated whether the core clock component nuclear receptor subfamily 1 group D member 1 (NR1D1, also called Rev-erbα) regulates expression, activity of the NLRP3 inflammasome, and its signaling pathway.
We collected naïve peritoneal macrophages and plasma, at multiple times of day, from Nr1d1–/– mice and their Nr1d1+/+ littermates (controls) and analyzed expression NLRP3, interleukin 1β (IL1B, in plasma), and IL18 (in plasma). We also collected bone marrow–derived primary macrophages from these mice. Levels of NR1D1 were knocked down with small hairpin RNAs in human primary macrophages. Bone marrow–derived primary macrophages from mice and human primary macrophages were incubated with lipopolysaccharide (LPS) to induce expression of NLRP3, IL1B, and IL18; cells were incubated with LPS and adenosine triphosphate to activate the NLRP3 complex. We analyzed caspase 1 activity and cytokine secretion. NR1D1 was activated in primary mouse and human macrophages by incubation with SR9009; some of the cells were also incubated with an NLRP3 inhibitor or inhibitors of caspase 1. Nr1d1–/– mice and control mice were given intraperitoneal injections of LPS to induce peritoneal inflammation; plasma samples were isolated and levels of cytokines were measured. Nr1d1–/– mice, control mice, and control mice given injections of SR9009 were given LPS and D-galactosamine to induce fulminant hepatitis and MCC950 to specifically inhibit NLRP3; plasma was collected to measure cytokines and a marker of liver failure (alanine aminotransferase); liver tissues were collected and analyzed by quantitative polymerase chain reaction, immunohistochemistry, and flow cytometry.
In peritoneal macrophages, expression of NLRP3 and activation of its complex varied with time of day (circadian rhythm)—this regulation required NR1D1. Primary macrophages from Nr1d1–/– mice and human macrophages with knockdown of NR1D1 had altered expression patterns of NLRP3, compared to macrophages that expressed NR1D1, and altered patterns of IL1B and 1L18 production. Mice with disruption of Nr1d1 developed more-severe acute peritoneal inflammation and fulminant hepatitis than co |
doi_str_mv | 10.1053/j.gastro.2017.12.019 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5892845</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0016508517367252</els_id><sourcerecordid>1980542327</sourcerecordid><originalsourceid>FETCH-LOGICAL-c566t-c59b7313f1ed84dd9ef32cbdfd00194c33569a9ad176157bf94f123e96f53ebb3</originalsourceid><addsrcrecordid>eNp9UsuO0zAUjRCIKYU_QMhLFjT4ESfxBqkqzHSkzoA6sLYc-6Z1lcTFdir1R_heXLUMjwUbX8s-Dx_fm2WvCc4J5uz9Lt-oEL3LKSZVTmiOiXiSTQin9QxjQp9mk1TKGcc1v8pehLDDGAtWk-fZFRW0qnhJJtmP-1F3oDxag4Z9dB49jE2retsdEUE33o179BHdQd-ATwdr2IydihDQwnqtjFUDmutoDzYekWvR_Wr9haHboe1U36vgekDRJZYZddptAT3AAfwFfD12vR3UENES9iraaAOyA7qzGl5mz1rVBXh1qdPs2_Wnr4vlbPX55nYxX800L8uYVtFUjLCWgKkLYwS0jOrGtCZFF4VmjJdCCWVIVRJeNa0oWkIZiLLlDJqGTbMPZ9392PRgNAzRq07uve2VP0qnrPz7ZrBbuXEHyWtB64IngXdnge0_tOV8Je0QwPcy9Se9hrEDSfC3Fz_vvo8Qouxt0NB1agA3BklEjXlBGa0StDhDtXcheGgf5QmWpwmQO3meAHmaAEmoPLlMszd_Jnok_Wr578iQ_vVgwcugLQwajPWgozTO_t_hJ5CgxeY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1980542327</pqid></control><display><type>article</type><title>Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Alma/SFX Local Collection</source><creator>Pourcet, Benoit ; Zecchin, Mathilde ; Ferri, Lise ; Beauchamp, Justine ; Sitaula, Sadicha ; Billon, Cyrielle ; Delhaye, Stéphane ; Vanhoutte, Jonathan ; Mayeuf-Louchart, Alicia ; Thorel, Quentin ; Haas, Joel T. ; Eeckhoute, Jérome ; Dombrowicz, David ; Duhem, Christian ; Boulinguiez, Alexis ; Lancel, Steve ; Sebti, Yasmine ; Burris, Thomas P. ; Staels, Bart ; Duez, Hélène M.</creator><creatorcontrib>Pourcet, Benoit ; Zecchin, Mathilde ; Ferri, Lise ; Beauchamp, Justine ; Sitaula, Sadicha ; Billon, Cyrielle ; Delhaye, Stéphane ; Vanhoutte, Jonathan ; Mayeuf-Louchart, Alicia ; Thorel, Quentin ; Haas, Joel T. ; Eeckhoute, Jérome ; Dombrowicz, David ; Duhem, Christian ; Boulinguiez, Alexis ; Lancel, Steve ; Sebti, Yasmine ; Burris, Thomas P. ; Staels, Bart ; Duez, Hélène M.</creatorcontrib><description>The innate immune system responds not only to bacterial signals, but also to non-infectious danger-associated molecular patterns that activate the NLRP3 inflammasome complex after tissue injury. Immune functions vary over the course of the day, but it is not clear whether these changes affect the activity of the NLRP3 inflammasome. We investigated whether the core clock component nuclear receptor subfamily 1 group D member 1 (NR1D1, also called Rev-erbα) regulates expression, activity of the NLRP3 inflammasome, and its signaling pathway.
We collected naïve peritoneal macrophages and plasma, at multiple times of day, from Nr1d1–/– mice and their Nr1d1+/+ littermates (controls) and analyzed expression NLRP3, interleukin 1β (IL1B, in plasma), and IL18 (in plasma). We also collected bone marrow–derived primary macrophages from these mice. Levels of NR1D1 were knocked down with small hairpin RNAs in human primary macrophages. Bone marrow–derived primary macrophages from mice and human primary macrophages were incubated with lipopolysaccharide (LPS) to induce expression of NLRP3, IL1B, and IL18; cells were incubated with LPS and adenosine triphosphate to activate the NLRP3 complex. We analyzed caspase 1 activity and cytokine secretion. NR1D1 was activated in primary mouse and human macrophages by incubation with SR9009; some of the cells were also incubated with an NLRP3 inhibitor or inhibitors of caspase 1. Nr1d1–/– mice and control mice were given intraperitoneal injections of LPS to induce peritoneal inflammation; plasma samples were isolated and levels of cytokines were measured. Nr1d1–/– mice, control mice, and control mice given injections of SR9009 were given LPS and D-galactosamine to induce fulminant hepatitis and MCC950 to specifically inhibit NLRP3; plasma was collected to measure cytokines and a marker of liver failure (alanine aminotransferase); liver tissues were collected and analyzed by quantitative polymerase chain reaction, immunohistochemistry, and flow cytometry.
In peritoneal macrophages, expression of NLRP3 and activation of its complex varied with time of day (circadian rhythm)—this regulation required NR1D1. Primary macrophages from Nr1d1–/– mice and human macrophages with knockdown of NR1D1 had altered expression patterns of NLRP3, compared to macrophages that expressed NR1D1, and altered patterns of IL1B and 1L18 production. Mice with disruption of Nr1d1 developed more-severe acute peritoneal inflammation and fulminant hepatitis than control mice. Incubation of macrophage with the NR1D1 activator SR9009 reduced expression of NLRP3 and secretion of cytokines. Mice given SR9009 developed less-severe liver failure and had longer survival times than mice given saline (control).
In studies of Nr1d1–/– mice and human macrophages with pharmacologic activation of NR1D1, we found NR1D1 to regulate the timing of NLRP3 expression and production of inflammatory cytokines by macrophages. Activation of NR1D1 reduced the severity of peritoneal inflammation and fulminant hepatitis in mice.
[Display omitted]</description><identifier>ISSN: 0016-5085</identifier><identifier>EISSN: 1528-0012</identifier><identifier>DOI: 10.1053/j.gastro.2017.12.019</identifier><identifier>PMID: 29277561</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute Liver Failure ; Animals ; Biological Clock ; Caspase 1 - metabolism ; Cells, Cultured ; Chemical and Drug Induced Liver Injury - immunology ; Chemical and Drug Induced Liver Injury - metabolism ; Chemical and Drug Induced Liver Injury - pathology ; Chemical and Drug Induced Liver Injury - prevention & control ; Circadian Rhythm ; Cytokines - metabolism ; Disease Models, Animal ; Galactosamine ; Genetic Predisposition to Disease ; Human health and pathology ; Immune Regulation ; Inflammasomes - genetics ; Inflammasomes - immunology ; Inflammasomes - metabolism ; Life Sciences ; Lipopolysaccharides ; Liver - drug effects ; Liver - immunology ; Liver - metabolism ; Liver - pathology ; Liver Failure, Acute - immunology ; Liver Failure, Acute - metabolism ; Liver Failure, Acute - pathology ; Liver Failure, Acute - prevention & control ; Macrophage Activation ; Macrophages, Peritoneal - drug effects ; Macrophages, Peritoneal - immunology ; Macrophages, Peritoneal - metabolism ; Macrophages, Peritoneal - pathology ; Mice, Knockout ; NLR Family, Pyrin Domain-Containing 3 Protein - genetics ; NLR Family, Pyrin Domain-Containing 3 Protein - metabolism ; Nuclear Receptor Subfamily 1, Group D, Member 1 - agonists ; Nuclear Receptor Subfamily 1, Group D, Member 1 - deficiency ; Nuclear Receptor Subfamily 1, Group D, Member 1 - genetics ; Nuclear Receptor Subfamily 1, Group D, Member 1 - metabolism ; Peritonitis - immunology ; Peritonitis - metabolism ; Peritonitis - prevention & control ; Phenotype ; Pyrrolidines - pharmacology ; Rev-erbα ; RNA Interference ; Severity of Illness Index ; Signal Transduction ; Thiophenes - pharmacology ; Time Factors ; Transfection</subject><ispartof>Gastroenterology (New York, N.Y. 1943), 2018-04, Vol.154 (5), p.1449-1464.e20</ispartof><rights>2018 AGA Institute</rights><rights>Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c566t-c59b7313f1ed84dd9ef32cbdfd00194c33569a9ad176157bf94f123e96f53ebb3</citedby><cites>FETCH-LOGICAL-c566t-c59b7313f1ed84dd9ef32cbdfd00194c33569a9ad176157bf94f123e96f53ebb3</cites><orcidid>0000-0002-0485-8923 ; 0000-0002-4130-7987 ; 0000-0002-7222-9264 ; 0000-0001-6886-6140 ; 0000-0002-3292-5433 ; 0000-0002-3784-1503</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0016508517367252$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29277561$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inserm.hal.science/inserm-01701933$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Pourcet, Benoit</creatorcontrib><creatorcontrib>Zecchin, Mathilde</creatorcontrib><creatorcontrib>Ferri, Lise</creatorcontrib><creatorcontrib>Beauchamp, Justine</creatorcontrib><creatorcontrib>Sitaula, Sadicha</creatorcontrib><creatorcontrib>Billon, Cyrielle</creatorcontrib><creatorcontrib>Delhaye, Stéphane</creatorcontrib><creatorcontrib>Vanhoutte, Jonathan</creatorcontrib><creatorcontrib>Mayeuf-Louchart, Alicia</creatorcontrib><creatorcontrib>Thorel, Quentin</creatorcontrib><creatorcontrib>Haas, Joel T.</creatorcontrib><creatorcontrib>Eeckhoute, Jérome</creatorcontrib><creatorcontrib>Dombrowicz, David</creatorcontrib><creatorcontrib>Duhem, Christian</creatorcontrib><creatorcontrib>Boulinguiez, Alexis</creatorcontrib><creatorcontrib>Lancel, Steve</creatorcontrib><creatorcontrib>Sebti, Yasmine</creatorcontrib><creatorcontrib>Burris, Thomas P.</creatorcontrib><creatorcontrib>Staels, Bart</creatorcontrib><creatorcontrib>Duez, Hélène M.</creatorcontrib><title>Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice</title><title>Gastroenterology (New York, N.Y. 1943)</title><addtitle>Gastroenterology</addtitle><description>The innate immune system responds not only to bacterial signals, but also to non-infectious danger-associated molecular patterns that activate the NLRP3 inflammasome complex after tissue injury. Immune functions vary over the course of the day, but it is not clear whether these changes affect the activity of the NLRP3 inflammasome. We investigated whether the core clock component nuclear receptor subfamily 1 group D member 1 (NR1D1, also called Rev-erbα) regulates expression, activity of the NLRP3 inflammasome, and its signaling pathway.
We collected naïve peritoneal macrophages and plasma, at multiple times of day, from Nr1d1–/– mice and their Nr1d1+/+ littermates (controls) and analyzed expression NLRP3, interleukin 1β (IL1B, in plasma), and IL18 (in plasma). We also collected bone marrow–derived primary macrophages from these mice. Levels of NR1D1 were knocked down with small hairpin RNAs in human primary macrophages. Bone marrow–derived primary macrophages from mice and human primary macrophages were incubated with lipopolysaccharide (LPS) to induce expression of NLRP3, IL1B, and IL18; cells were incubated with LPS and adenosine triphosphate to activate the NLRP3 complex. We analyzed caspase 1 activity and cytokine secretion. NR1D1 was activated in primary mouse and human macrophages by incubation with SR9009; some of the cells were also incubated with an NLRP3 inhibitor or inhibitors of caspase 1. Nr1d1–/– mice and control mice were given intraperitoneal injections of LPS to induce peritoneal inflammation; plasma samples were isolated and levels of cytokines were measured. Nr1d1–/– mice, control mice, and control mice given injections of SR9009 were given LPS and D-galactosamine to induce fulminant hepatitis and MCC950 to specifically inhibit NLRP3; plasma was collected to measure cytokines and a marker of liver failure (alanine aminotransferase); liver tissues were collected and analyzed by quantitative polymerase chain reaction, immunohistochemistry, and flow cytometry.
In peritoneal macrophages, expression of NLRP3 and activation of its complex varied with time of day (circadian rhythm)—this regulation required NR1D1. Primary macrophages from Nr1d1–/– mice and human macrophages with knockdown of NR1D1 had altered expression patterns of NLRP3, compared to macrophages that expressed NR1D1, and altered patterns of IL1B and 1L18 production. Mice with disruption of Nr1d1 developed more-severe acute peritoneal inflammation and fulminant hepatitis than control mice. Incubation of macrophage with the NR1D1 activator SR9009 reduced expression of NLRP3 and secretion of cytokines. Mice given SR9009 developed less-severe liver failure and had longer survival times than mice given saline (control).
In studies of Nr1d1–/– mice and human macrophages with pharmacologic activation of NR1D1, we found NR1D1 to regulate the timing of NLRP3 expression and production of inflammatory cytokines by macrophages. Activation of NR1D1 reduced the severity of peritoneal inflammation and fulminant hepatitis in mice.
[Display omitted]</description><subject>Acute Liver Failure</subject><subject>Animals</subject><subject>Biological Clock</subject><subject>Caspase 1 - metabolism</subject><subject>Cells, Cultured</subject><subject>Chemical and Drug Induced Liver Injury - immunology</subject><subject>Chemical and Drug Induced Liver Injury - metabolism</subject><subject>Chemical and Drug Induced Liver Injury - pathology</subject><subject>Chemical and Drug Induced Liver Injury - prevention & control</subject><subject>Circadian Rhythm</subject><subject>Cytokines - metabolism</subject><subject>Disease Models, Animal</subject><subject>Galactosamine</subject><subject>Genetic Predisposition to Disease</subject><subject>Human health and pathology</subject><subject>Immune Regulation</subject><subject>Inflammasomes - genetics</subject><subject>Inflammasomes - immunology</subject><subject>Inflammasomes - metabolism</subject><subject>Life Sciences</subject><subject>Lipopolysaccharides</subject><subject>Liver - drug effects</subject><subject>Liver - immunology</subject><subject>Liver - metabolism</subject><subject>Liver - pathology</subject><subject>Liver Failure, Acute - immunology</subject><subject>Liver Failure, Acute - metabolism</subject><subject>Liver Failure, Acute - pathology</subject><subject>Liver Failure, Acute - prevention & control</subject><subject>Macrophage Activation</subject><subject>Macrophages, Peritoneal - drug effects</subject><subject>Macrophages, Peritoneal - immunology</subject><subject>Macrophages, Peritoneal - metabolism</subject><subject>Macrophages, Peritoneal - pathology</subject><subject>Mice, Knockout</subject><subject>NLR Family, Pyrin Domain-Containing 3 Protein - genetics</subject><subject>NLR Family, Pyrin Domain-Containing 3 Protein - metabolism</subject><subject>Nuclear Receptor Subfamily 1, Group D, Member 1 - agonists</subject><subject>Nuclear Receptor Subfamily 1, Group D, Member 1 - deficiency</subject><subject>Nuclear Receptor Subfamily 1, Group D, Member 1 - genetics</subject><subject>Nuclear Receptor Subfamily 1, Group D, Member 1 - metabolism</subject><subject>Peritonitis - immunology</subject><subject>Peritonitis - metabolism</subject><subject>Peritonitis - prevention & control</subject><subject>Phenotype</subject><subject>Pyrrolidines - pharmacology</subject><subject>Rev-erbα</subject><subject>RNA Interference</subject><subject>Severity of Illness Index</subject><subject>Signal Transduction</subject><subject>Thiophenes - pharmacology</subject><subject>Time Factors</subject><subject>Transfection</subject><issn>0016-5085</issn><issn>1528-0012</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UsuO0zAUjRCIKYU_QMhLFjT4ESfxBqkqzHSkzoA6sLYc-6Z1lcTFdir1R_heXLUMjwUbX8s-Dx_fm2WvCc4J5uz9Lt-oEL3LKSZVTmiOiXiSTQin9QxjQp9mk1TKGcc1v8pehLDDGAtWk-fZFRW0qnhJJtmP-1F3oDxag4Z9dB49jE2retsdEUE33o179BHdQd-ATwdr2IydihDQwnqtjFUDmutoDzYekWvR_Wr9haHboe1U36vgekDRJZYZddptAT3AAfwFfD12vR3UENES9iraaAOyA7qzGl5mz1rVBXh1qdPs2_Wnr4vlbPX55nYxX800L8uYVtFUjLCWgKkLYwS0jOrGtCZFF4VmjJdCCWVIVRJeNa0oWkIZiLLlDJqGTbMPZ9392PRgNAzRq07uve2VP0qnrPz7ZrBbuXEHyWtB64IngXdnge0_tOV8Je0QwPcy9Se9hrEDSfC3Fz_vvo8Qouxt0NB1agA3BklEjXlBGa0StDhDtXcheGgf5QmWpwmQO3meAHmaAEmoPLlMszd_Jnok_Wr578iQ_vVgwcugLQwajPWgozTO_t_hJ5CgxeY</recordid><startdate>20180401</startdate><enddate>20180401</enddate><creator>Pourcet, Benoit</creator><creator>Zecchin, Mathilde</creator><creator>Ferri, Lise</creator><creator>Beauchamp, Justine</creator><creator>Sitaula, Sadicha</creator><creator>Billon, Cyrielle</creator><creator>Delhaye, Stéphane</creator><creator>Vanhoutte, Jonathan</creator><creator>Mayeuf-Louchart, Alicia</creator><creator>Thorel, Quentin</creator><creator>Haas, Joel T.</creator><creator>Eeckhoute, Jérome</creator><creator>Dombrowicz, David</creator><creator>Duhem, Christian</creator><creator>Boulinguiez, Alexis</creator><creator>Lancel, Steve</creator><creator>Sebti, Yasmine</creator><creator>Burris, Thomas P.</creator><creator>Staels, Bart</creator><creator>Duez, Hélène M.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0485-8923</orcidid><orcidid>https://orcid.org/0000-0002-4130-7987</orcidid><orcidid>https://orcid.org/0000-0002-7222-9264</orcidid><orcidid>https://orcid.org/0000-0001-6886-6140</orcidid><orcidid>https://orcid.org/0000-0002-3292-5433</orcidid><orcidid>https://orcid.org/0000-0002-3784-1503</orcidid></search><sort><creationdate>20180401</creationdate><title>Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice</title><author>Pourcet, Benoit ; Zecchin, Mathilde ; Ferri, Lise ; Beauchamp, Justine ; Sitaula, Sadicha ; Billon, Cyrielle ; Delhaye, Stéphane ; Vanhoutte, Jonathan ; Mayeuf-Louchart, Alicia ; Thorel, Quentin ; Haas, Joel T. ; Eeckhoute, Jérome ; Dombrowicz, David ; Duhem, Christian ; Boulinguiez, Alexis ; Lancel, Steve ; Sebti, Yasmine ; Burris, Thomas P. ; Staels, Bart ; Duez, Hélène M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c566t-c59b7313f1ed84dd9ef32cbdfd00194c33569a9ad176157bf94f123e96f53ebb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acute Liver Failure</topic><topic>Animals</topic><topic>Biological Clock</topic><topic>Caspase 1 - metabolism</topic><topic>Cells, Cultured</topic><topic>Chemical and Drug Induced Liver Injury - immunology</topic><topic>Chemical and Drug Induced Liver Injury - metabolism</topic><topic>Chemical and Drug Induced Liver Injury - pathology</topic><topic>Chemical and Drug Induced Liver Injury - prevention & control</topic><topic>Circadian Rhythm</topic><topic>Cytokines - metabolism</topic><topic>Disease Models, Animal</topic><topic>Galactosamine</topic><topic>Genetic Predisposition to Disease</topic><topic>Human health and pathology</topic><topic>Immune Regulation</topic><topic>Inflammasomes - genetics</topic><topic>Inflammasomes - immunology</topic><topic>Inflammasomes - metabolism</topic><topic>Life Sciences</topic><topic>Lipopolysaccharides</topic><topic>Liver - drug effects</topic><topic>Liver - immunology</topic><topic>Liver - metabolism</topic><topic>Liver - pathology</topic><topic>Liver Failure, Acute - immunology</topic><topic>Liver Failure, Acute - metabolism</topic><topic>Liver Failure, Acute - pathology</topic><topic>Liver Failure, Acute - prevention & control</topic><topic>Macrophage Activation</topic><topic>Macrophages, Peritoneal - drug effects</topic><topic>Macrophages, Peritoneal - immunology</topic><topic>Macrophages, Peritoneal - metabolism</topic><topic>Macrophages, Peritoneal - pathology</topic><topic>Mice, Knockout</topic><topic>NLR Family, Pyrin Domain-Containing 3 Protein - genetics</topic><topic>NLR Family, Pyrin Domain-Containing 3 Protein - metabolism</topic><topic>Nuclear Receptor Subfamily 1, Group D, Member 1 - agonists</topic><topic>Nuclear Receptor Subfamily 1, Group D, Member 1 - deficiency</topic><topic>Nuclear Receptor Subfamily 1, Group D, Member 1 - genetics</topic><topic>Nuclear Receptor Subfamily 1, Group D, Member 1 - metabolism</topic><topic>Peritonitis - immunology</topic><topic>Peritonitis - metabolism</topic><topic>Peritonitis - prevention & control</topic><topic>Phenotype</topic><topic>Pyrrolidines - pharmacology</topic><topic>Rev-erbα</topic><topic>RNA Interference</topic><topic>Severity of Illness Index</topic><topic>Signal Transduction</topic><topic>Thiophenes - pharmacology</topic><topic>Time Factors</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pourcet, Benoit</creatorcontrib><creatorcontrib>Zecchin, Mathilde</creatorcontrib><creatorcontrib>Ferri, Lise</creatorcontrib><creatorcontrib>Beauchamp, Justine</creatorcontrib><creatorcontrib>Sitaula, Sadicha</creatorcontrib><creatorcontrib>Billon, Cyrielle</creatorcontrib><creatorcontrib>Delhaye, Stéphane</creatorcontrib><creatorcontrib>Vanhoutte, Jonathan</creatorcontrib><creatorcontrib>Mayeuf-Louchart, Alicia</creatorcontrib><creatorcontrib>Thorel, Quentin</creatorcontrib><creatorcontrib>Haas, Joel T.</creatorcontrib><creatorcontrib>Eeckhoute, Jérome</creatorcontrib><creatorcontrib>Dombrowicz, David</creatorcontrib><creatorcontrib>Duhem, Christian</creatorcontrib><creatorcontrib>Boulinguiez, Alexis</creatorcontrib><creatorcontrib>Lancel, Steve</creatorcontrib><creatorcontrib>Sebti, Yasmine</creatorcontrib><creatorcontrib>Burris, Thomas P.</creatorcontrib><creatorcontrib>Staels, Bart</creatorcontrib><creatorcontrib>Duez, Hélène M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pourcet, Benoit</au><au>Zecchin, Mathilde</au><au>Ferri, Lise</au><au>Beauchamp, Justine</au><au>Sitaula, Sadicha</au><au>Billon, Cyrielle</au><au>Delhaye, Stéphane</au><au>Vanhoutte, Jonathan</au><au>Mayeuf-Louchart, Alicia</au><au>Thorel, Quentin</au><au>Haas, Joel T.</au><au>Eeckhoute, Jérome</au><au>Dombrowicz, David</au><au>Duhem, Christian</au><au>Boulinguiez, Alexis</au><au>Lancel, Steve</au><au>Sebti, Yasmine</au><au>Burris, Thomas P.</au><au>Staels, Bart</au><au>Duez, Hélène M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice</atitle><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle><addtitle>Gastroenterology</addtitle><date>2018-04-01</date><risdate>2018</risdate><volume>154</volume><issue>5</issue><spage>1449</spage><epage>1464.e20</epage><pages>1449-1464.e20</pages><issn>0016-5085</issn><eissn>1528-0012</eissn><abstract>The innate immune system responds not only to bacterial signals, but also to non-infectious danger-associated molecular patterns that activate the NLRP3 inflammasome complex after tissue injury. Immune functions vary over the course of the day, but it is not clear whether these changes affect the activity of the NLRP3 inflammasome. We investigated whether the core clock component nuclear receptor subfamily 1 group D member 1 (NR1D1, also called Rev-erbα) regulates expression, activity of the NLRP3 inflammasome, and its signaling pathway.
We collected naïve peritoneal macrophages and plasma, at multiple times of day, from Nr1d1–/– mice and their Nr1d1+/+ littermates (controls) and analyzed expression NLRP3, interleukin 1β (IL1B, in plasma), and IL18 (in plasma). We also collected bone marrow–derived primary macrophages from these mice. Levels of NR1D1 were knocked down with small hairpin RNAs in human primary macrophages. Bone marrow–derived primary macrophages from mice and human primary macrophages were incubated with lipopolysaccharide (LPS) to induce expression of NLRP3, IL1B, and IL18; cells were incubated with LPS and adenosine triphosphate to activate the NLRP3 complex. We analyzed caspase 1 activity and cytokine secretion. NR1D1 was activated in primary mouse and human macrophages by incubation with SR9009; some of the cells were also incubated with an NLRP3 inhibitor or inhibitors of caspase 1. Nr1d1–/– mice and control mice were given intraperitoneal injections of LPS to induce peritoneal inflammation; plasma samples were isolated and levels of cytokines were measured. Nr1d1–/– mice, control mice, and control mice given injections of SR9009 were given LPS and D-galactosamine to induce fulminant hepatitis and MCC950 to specifically inhibit NLRP3; plasma was collected to measure cytokines and a marker of liver failure (alanine aminotransferase); liver tissues were collected and analyzed by quantitative polymerase chain reaction, immunohistochemistry, and flow cytometry.
In peritoneal macrophages, expression of NLRP3 and activation of its complex varied with time of day (circadian rhythm)—this regulation required NR1D1. Primary macrophages from Nr1d1–/– mice and human macrophages with knockdown of NR1D1 had altered expression patterns of NLRP3, compared to macrophages that expressed NR1D1, and altered patterns of IL1B and 1L18 production. Mice with disruption of Nr1d1 developed more-severe acute peritoneal inflammation and fulminant hepatitis than control mice. Incubation of macrophage with the NR1D1 activator SR9009 reduced expression of NLRP3 and secretion of cytokines. Mice given SR9009 developed less-severe liver failure and had longer survival times than mice given saline (control).
In studies of Nr1d1–/– mice and human macrophages with pharmacologic activation of NR1D1, we found NR1D1 to regulate the timing of NLRP3 expression and production of inflammatory cytokines by macrophages. Activation of NR1D1 reduced the severity of peritoneal inflammation and fulminant hepatitis in mice.
[Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29277561</pmid><doi>10.1053/j.gastro.2017.12.019</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0002-0485-8923</orcidid><orcidid>https://orcid.org/0000-0002-4130-7987</orcidid><orcidid>https://orcid.org/0000-0002-7222-9264</orcidid><orcidid>https://orcid.org/0000-0001-6886-6140</orcidid><orcidid>https://orcid.org/0000-0002-3292-5433</orcidid><orcidid>https://orcid.org/0000-0002-3784-1503</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0016-5085 |
ispartof | Gastroenterology (New York, N.Y. 1943), 2018-04, Vol.154 (5), p.1449-1464.e20 |
issn | 0016-5085 1528-0012 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5892845 |
source | MEDLINE; Elsevier ScienceDirect Journals; Alma/SFX Local Collection |
subjects | Acute Liver Failure Animals Biological Clock Caspase 1 - metabolism Cells, Cultured Chemical and Drug Induced Liver Injury - immunology Chemical and Drug Induced Liver Injury - metabolism Chemical and Drug Induced Liver Injury - pathology Chemical and Drug Induced Liver Injury - prevention & control Circadian Rhythm Cytokines - metabolism Disease Models, Animal Galactosamine Genetic Predisposition to Disease Human health and pathology Immune Regulation Inflammasomes - genetics Inflammasomes - immunology Inflammasomes - metabolism Life Sciences Lipopolysaccharides Liver - drug effects Liver - immunology Liver - metabolism Liver - pathology Liver Failure, Acute - immunology Liver Failure, Acute - metabolism Liver Failure, Acute - pathology Liver Failure, Acute - prevention & control Macrophage Activation Macrophages, Peritoneal - drug effects Macrophages, Peritoneal - immunology Macrophages, Peritoneal - metabolism Macrophages, Peritoneal - pathology Mice, Knockout NLR Family, Pyrin Domain-Containing 3 Protein - genetics NLR Family, Pyrin Domain-Containing 3 Protein - metabolism Nuclear Receptor Subfamily 1, Group D, Member 1 - agonists Nuclear Receptor Subfamily 1, Group D, Member 1 - deficiency Nuclear Receptor Subfamily 1, Group D, Member 1 - genetics Nuclear Receptor Subfamily 1, Group D, Member 1 - metabolism Peritonitis - immunology Peritonitis - metabolism Peritonitis - prevention & control Phenotype Pyrrolidines - pharmacology Rev-erbα RNA Interference Severity of Illness Index Signal Transduction Thiophenes - pharmacology Time Factors Transfection |
title | Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T15%3A32%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nuclear%20Receptor%20Subfamily%201%20Group%20D%20Member%201%20Regulates%20Circadian%20Activity%20of%20NLRP3%20Inflammasome%20to%20Reduce%20the%20Severity%20of%20Fulminant%20Hepatitis%20in%20Mice&rft.jtitle=Gastroenterology%20(New%20York,%20N.Y.%201943)&rft.au=Pourcet,%20Benoit&rft.date=2018-04-01&rft.volume=154&rft.issue=5&rft.spage=1449&rft.epage=1464.e20&rft.pages=1449-1464.e20&rft.issn=0016-5085&rft.eissn=1528-0012&rft_id=info:doi/10.1053/j.gastro.2017.12.019&rft_dat=%3Cproquest_pubme%3E1980542327%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1980542327&rft_id=info:pmid/29277561&rft_els_id=S0016508517367252&rfr_iscdi=true |